CIK: 1592380 - Address: C/o Clearside Biomedical, Inc., 900 North Point Parkway, Suite 200, Alpharetta, GA 30005
34 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11110-418124035
P%wins100100010010080
S%ret116-14-28124027
S%wins67178050043

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/25/23 16:34
9/25/23
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADP90.860001003,586D
5/19/23 16:18
5/19/23
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayDEDM.d00.000403,582D
12/21/22 16:26
12/21/22
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADP141.0201403,576D
12/19/22 19:40
2/10/21
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADS.a-1464.430-33-14,952D
5/17/22 21:06
5/16/22
VIGLVigil Neuroscience, Inc.DEHealthBioPrdBiological Products, (No DiagThorp ClayMADP.m1042.8503721,559I
3/28/22 16:44
3/28/22
VIGLVigil Neuroscience, Inc.DEHealthBioPrdBiological Products, (No DiagThorp ClayMADP227.200301,522D
1/11/22 21:20
1/11/22
VIGLVigil Neuroscience, Inc.DEHealthBioPrdBiological Products, (No DiagThorp ClayMADP.d3,71014.000265211,519I
8/18/21 18:07
8/18/21
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADP303.000104433D
2/12/21 17:22
2/10/21
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADS-1464.430-33-13,442I
11/24/20 16:04
11/23/20
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADP.m183.60052823D
7/3/19 16:28
7/1/19
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADTS-4114.000-302,450I
6/20/19 19:09
6/18/19
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADTS-614.000002,453I
12/6/18 17:41
12/6/18
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTP111.360803,474D
12/6/18 09:15
12/4/18
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADTP133.130402,474D
10/24/18 16:19
10/22/18
PHASPhasebio Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsThorp ClayPADTP.d1,5005.000300142,470I
6/1/18 18:22
5/30/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayNCTS-38,40048.000-800-203,238I
5/23/18 20:46
5/21/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayNCTS.m-1,91751.110-38-14,038I
5/21/18 16:05
5/17/18
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-2,10813.080-161-43,466I
3/23/18 17:51
3/21/18
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-1,69612.210-139-43,628I
12/7/17 17:10
12/5/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-2186.220-35-13,766I
11/16/17 17:41
11/14/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-2457.000-35-13,801I
10/5/17 19:35
10/3/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-3008.570-35-13,836I
9/15/17 17:08
9/13/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-1847.520-25-13,871I
8/9/17 17:48
8/7/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-1857.570-25-13,896I
5/24/17 20:18
5/22/17
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayNCTP.d2,00015.00013334,174I
5/19/17 18:11
5/18/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-2018.361-24-13,920I-491613191014
5/17/17 19:43
5/15/17
CLSDClearside Biomedical, Inc.GAHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-3848.631-44-13,944I-491613191014
4/19/17 20:12
4/17/17
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-5117.461-68-23,989I-63-164-2-5-213
3/17/17 16:19
3/15/17
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-4506.562-68-24,057I-10-14-1-930028
2/22/17 16:36
2/21/17
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-2047.551-27-14,126I9-65-18310-49-3
2/17/17 19:32
2/15/17
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-3157.601-41-14,153I9-63-24-38105-10
1/20/17 20:19
1/17/17
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.m-5848.532-68-24,194I25-62-46-9-12-11-350-2
6/7/16 16:31
6/7/16
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTS.d-17.007004,263I10-418124
6/7/16 16:31
6/7/16
CLSDClearside Biomedical, Inc.DEHealthDrugPharmaceutical PreparationsThorp ClayGADTP.d5,5007.007786234,263I10-418124

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact